Skip to main content
Top
Published in: BMC Pediatrics 1/2015

Open Access 01-12-2015 | Research article

Evaluation of a simple intervention to reduce exchange transfusion rates among inborn and outborn neonates in Myanmar, comparing pre- and post-intervention rates

Authors: G. Arnolda, A. A. Thein, D. Trevisanuto, N. Aung, H. M Nwe, A. A. Thin, N. S. S. Aye, T. Defechereux, D. Kumara, L. Moccia

Published in: BMC Pediatrics | Issue 1/2015

Login to get access

Abstract

Background

In Myanmar, approximately half of all neonatal hospital admissions are for hyperbilirubinaemia, and tertiary facilities report high rates of Exchange Transfusion (ET). The aim of this study was to evaluate the effectiveness of the pilot program in reducing ET, separately of inborn and outborn neonates.

Methods

The study was conducted in the Neonatal Care Units of four national tertiary hospitals: two exclusively treating inborn neonates, and two solely for outborn neonates. Prior to intervention, no high intensity phototherapy was available in these units. Intervention in late November 2011 comprised, for each hospital, provision of two high intensity LED phototherapy machines, a photo radiometer, and training of personnel. Hospital-specific data were assessed as Relative Risk (RR) ratios comparing ET rates pre- and post-intervention, and individual hospital results were pooled when appropriate.

Results

In 2011, there were 118 ETs among inborn neonates and 140 ETs among outborn neonates. The ET rate was unchanged at Inborn Hospital A (RR = 1.07; 95 % CI: 0.80–1.43; p = 0.67), and reduced by 69 % at Inborn Hospital B (RR = 0.31; 95 % CI: 0.17–0.57; p < 0.0001). For outborn neonates, the pooled estimate indicated that ET rates reduced by 33 % post-intervention (RRMH = 0.67; 95 % CI: 0.52–0.87; p = 0.002); heterogeneity was not a problem.

Conclusion

Together with a photoradiometer and education, intensive phototherapy can significantly reduce the ET rate. Inborn Hospital A had four times as many admissions for jaundice as Inborn Hospital B, and did not reduce ET until it received additional high intensity machines. The results highlight the importance of providing enough intensive phototherapy units to treat all neonates requiring high intensity treatment for a full course.

Trial registration

Australian New Zealand Clinical Trials Registry ACTRN12615001171​505, 2 November 2015.
Literature
2.
go back to reference Maisels MJ. Neonatal jaundice. In: Sinclair JC, Bracken MB, editors. Effective care of the newborn infant. Oxford: Oxford University Press; 1992. p. 507–61. Maisels MJ. Neonatal jaundice. In: Sinclair JC, Bracken MB, editors. Effective care of the newborn infant. Oxford: Oxford University Press; 1992. p. 507–61.
3.
go back to reference Stevenson DK, Wong RJ. Metalloporphyrins in the management of neonatal hyperbilirubinemia. Semin Fetal Neonatal Med. 2010;15(3):164–8.CrossRefPubMed Stevenson DK, Wong RJ. Metalloporphyrins in the management of neonatal hyperbilirubinemia. Semin Fetal Neonatal Med. 2010;15(3):164–8.CrossRefPubMed
4.
go back to reference Murki S, Kumar P. Blood exchange transfusion for infants with severe neonatal hyperbilirubinemia. Semin Perinatol. 2011;35(3):175–84.CrossRefPubMed Murki S, Kumar P. Blood exchange transfusion for infants with severe neonatal hyperbilirubinemia. Semin Perinatol. 2011;35(3):175–84.CrossRefPubMed
5.
go back to reference Murray NA, Roberts IAG. Neonatal transfusion practice. Arch Dis Child Fetal Neonatal Ed. 2004;89(2):101–7.CrossRef Murray NA, Roberts IAG. Neonatal transfusion practice. Arch Dis Child Fetal Neonatal Ed. 2004;89(2):101–7.CrossRef
6.
go back to reference Valaes T, Koliopoulos C, Koltsidopoulos A. The impact of phototherapy in the management of neonatal hyperbilirubinemia: comparison of historical cohorts. Acta Paediatr. 1996;85(3):273–6.CrossRefPubMed Valaes T, Koliopoulos C, Koltsidopoulos A. The impact of phototherapy in the management of neonatal hyperbilirubinemia: comparison of historical cohorts. Acta Paediatr. 1996;85(3):273–6.CrossRefPubMed
7.
go back to reference Steiner LA, Bizzarro MJ, Ehrenkranz RA, Gallagher PG. A decline in the frequency of neonatal exchange transfusions and its effect on exchange-related morbidity and mortality. Pediatrics. 2007;12(1):27–32.CrossRef Steiner LA, Bizzarro MJ, Ehrenkranz RA, Gallagher PG. A decline in the frequency of neonatal exchange transfusions and its effect on exchange-related morbidity and mortality. Pediatrics. 2007;12(1):27–32.CrossRef
8.
go back to reference Brown AK, Kim MH, Wu PY, Bryla DA. Efficacy of phototherapy in prevention and management of neonatal hyperbilirubinemia. Pediatrics. 1985;75(2 Pt 2):393–400.PubMed Brown AK, Kim MH, Wu PY, Bryla DA. Efficacy of phototherapy in prevention and management of neonatal hyperbilirubinemia. Pediatrics. 1985;75(2 Pt 2):393–400.PubMed
9.
go back to reference Department of Health. Annual hospital statistics report: 2010–2011. Nay Pyi Taw, Myanmar: Department of Health Planning; 2013. Department of Health. Annual hospital statistics report: 2010–2011. Nay Pyi Taw, Myanmar: Department of Health Planning; 2013.
10.
go back to reference American Academy of Pediatrics. Levels of neonatal care. Pediatrics. 2004;114(5):1341–7.CrossRef American Academy of Pediatrics. Levels of neonatal care. Pediatrics. 2004;114(5):1341–7.CrossRef
14.
go back to reference American Academy of Pediatrics. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114:297–316.CrossRef American Academy of Pediatrics. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114:297–316.CrossRef
15.
go back to reference Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses, vol. 327. 2003. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses, vol. 327. 2003.
16.
go back to reference Review Manager (RevMan). Copenhagen: the nordic cochrane centre, the cochrane collaboration. 2012. Review Manager (RevMan). Copenhagen: the nordic cochrane centre, the cochrane collaboration. 2012.
18.
go back to reference Kitchen WH. Neonatal mortality in infants receiving an exchange transfusion. J Paediatr Child Health. 1970;6(1):30–40.CrossRef Kitchen WH. Neonatal mortality in infants receiving an exchange transfusion. J Paediatr Child Health. 1970;6(1):30–40.CrossRef
19.
go back to reference Panagopoulos G, Valaes T, Doxiadis SA. Morbidity and mortality related to exchangetransfusions. J Pediatr. 1969;74(2):247–54.CrossRefPubMed Panagopoulos G, Valaes T, Doxiadis SA. Morbidity and mortality related to exchangetransfusions. J Pediatr. 1969;74(2):247–54.CrossRefPubMed
20.
go back to reference Weldon VV, Odell GB. Mortality risk of exchange transfusion. Pediatrics. 1968;41(4):797–801.PubMed Weldon VV, Odell GB. Mortality risk of exchange transfusion. Pediatrics. 1968;41(4):797–801.PubMed
21.
go back to reference Boggs TR, Westphal MC. Mortality of exchange transfusion. Pediatrics. 1960;26(5):745–55. Boggs TR, Westphal MC. Mortality of exchange transfusion. Pediatrics. 1960;26(5):745–55.
22.
go back to reference Hovi L, Siimes MA. Exchange transfusion with fresh heparinized blood is a safe procedure. Acta Paediatr. 1985;74(3):360–5.CrossRef Hovi L, Siimes MA. Exchange transfusion with fresh heparinized blood is a safe procedure. Acta Paediatr. 1985;74(3):360–5.CrossRef
23.
go back to reference Guaran RL, Drew JH, Watkins AM. Jaundice: clinical practice in 88,000 liveborn infants. Aust N Z J Obstet Gynaecol. 1992;32(3):186–92.CrossRefPubMed Guaran RL, Drew JH, Watkins AM. Jaundice: clinical practice in 88,000 liveborn infants. Aust N Z J Obstet Gynaecol. 1992;32(3):186–92.CrossRefPubMed
24.
go back to reference Keenan WJ, Novak KK, Sutherland JM, Bryla DA, Fetterly KL. Morbidity and mortality associated with exchange transfusion. Pediatrics. 1985;75(2 Pt 2):417–21.PubMed Keenan WJ, Novak KK, Sutherland JM, Bryla DA, Fetterly KL. Morbidity and mortality associated with exchange transfusion. Pediatrics. 1985;75(2 Pt 2):417–21.PubMed
25.
go back to reference Sanpavat S. Exchange transfusion and its morbidity in ten-year period at King Chulalongkorn Hospital. J Med Assoc Thai. 2005;88(5):588–92.PubMed Sanpavat S. Exchange transfusion and its morbidity in ten-year period at King Chulalongkorn Hospital. J Med Assoc Thai. 2005;88(5):588–92.PubMed
26.
go back to reference Behjati S, Sagheb S, Aryasepehr S, Yaghmai B. Adverse events associated with neonatal exchange transfusion for hyperbilirubinemia. Indian J Pediatr. 2009;76(1):83–5.CrossRefPubMed Behjati S, Sagheb S, Aryasepehr S, Yaghmai B. Adverse events associated with neonatal exchange transfusion for hyperbilirubinemia. Indian J Pediatr. 2009;76(1):83–5.CrossRefPubMed
27.
go back to reference Hosseinpour Sakha S, Gharehbaghi MM. Exchange transfusion in severe hyperbilirubinemia: an experience in northwest Iran. Turk J Pediatr. 2010;52(4):367–71.PubMed Hosseinpour Sakha S, Gharehbaghi MM. Exchange transfusion in severe hyperbilirubinemia: an experience in northwest Iran. Turk J Pediatr. 2010;52(4):367–71.PubMed
28.
go back to reference Badiee Z. Exchange transfusion in neonatal hyperbilirubinaemia: experience in Isfahan. Iran Singapore Med J. 2007;48(5):421–3.PubMed Badiee Z. Exchange transfusion in neonatal hyperbilirubinaemia: experience in Isfahan. Iran Singapore Med J. 2007;48(5):421–3.PubMed
29.
go back to reference Bhat AW, Churoo B, Iqbal Q, Sheikh M, Iqbal J, Aziz R. Complication of exchange transfusion at a tertiary care hospital. Seizure. 2011;1:1. Bhat AW, Churoo B, Iqbal Q, Sheikh M, Iqbal J, Aziz R. Complication of exchange transfusion at a tertiary care hospital. Seizure. 2011;1:1.
30.
go back to reference Rasul CH, Hasan MA, Yasmin F. Outcome of neonatal hyperbilirubinemia in a tertiary care hospital in Bangladesh. MJMS. 2010;17(2):40.PubMedPubMedCentral Rasul CH, Hasan MA, Yasmin F. Outcome of neonatal hyperbilirubinemia in a tertiary care hospital in Bangladesh. MJMS. 2010;17(2):40.PubMedPubMedCentral
31.
go back to reference Patra K, Storfer-Isser A, Siner B, Moore J, Hack M. Adverse events associated with neonatal exchange transfusion in the 1990s. J Pediatr. 2004;144(5):626–31.CrossRefPubMed Patra K, Storfer-Isser A, Siner B, Moore J, Hack M. Adverse events associated with neonatal exchange transfusion in the 1990s. J Pediatr. 2004;144(5):626–31.CrossRefPubMed
32.
go back to reference Adebami OJ. Factors associated with the incidence of acute bilirubin encephalopathy in Nigerian population. J Pediatr Neurol. 2011;9(3):347–53. Adebami OJ. Factors associated with the incidence of acute bilirubin encephalopathy in Nigerian population. J Pediatr Neurol. 2011;9(3):347–53.
33.
go back to reference Eneh A, Oruamabo R. Neonatal jaundice in a special care baby unit (SCBU) in Port Harcourt, Nigeria: A prospective study. Port Harcourt Med J. 2008;2(2):110–7.CrossRef Eneh A, Oruamabo R. Neonatal jaundice in a special care baby unit (SCBU) in Port Harcourt, Nigeria: A prospective study. Port Harcourt Med J. 2008;2(2):110–7.CrossRef
34.
go back to reference Owa JA, Ogunlesi TA. Why we are still doing so many exchange blood transfusion for neonatal jaundice in Nigeria. World J Pediatr. 2009;5(2):51–5.CrossRefPubMed Owa JA, Ogunlesi TA. Why we are still doing so many exchange blood transfusion for neonatal jaundice in Nigeria. World J Pediatr. 2009;5(2):51–5.CrossRefPubMed
35.
go back to reference UNICEF. The state of the world’s children 2013. New York: United Nations Children’s Fund; 2013. UNICEF. The state of the world’s children 2013. New York: United Nations Children’s Fund; 2013.
Metadata
Title
Evaluation of a simple intervention to reduce exchange transfusion rates among inborn and outborn neonates in Myanmar, comparing pre- and post-intervention rates
Authors
G. Arnolda
A. A. Thein
D. Trevisanuto
N. Aung
H. M Nwe
A. A. Thin
N. S. S. Aye
T. Defechereux
D. Kumara
L. Moccia
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Pediatrics / Issue 1/2015
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/s12887-015-0530-5

Other articles of this Issue 1/2015

BMC Pediatrics 1/2015 Go to the issue